Stay updated with breaking news from Lumin Bioinformatics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HACKENSACK, NJ / ACCESSWIRE / May 3, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic
Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $10.8 Million HACKENSACK, NJ / ACCESSWIRE / March 11, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery and development through data-driven research strategies and innovative pharmacology, biomarker and data platforms, today announced its financial results for the third fiscal quarter ended January 31, 2021. Third Quarter and Recent Highlights: Delivered record quarterly revenue of $10.8 million, an increase of 20% year ov...
(2) HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-driven research strategies, announced today a partnership with Code Ocean to expand the functionality of its SaaS program, Lumin Bioinformatics. The partnership between Champions and Code Ocean will focus on enhancements involved in data integration and sharing workflows within the Lumin platform. Users will now be equipped with a robust methodology for centralizing, storing, and organizing la...